Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Lulli

1. How should the optimal reflux monitoring modality and protocol be selected for different reflux presentations?
2. Can patients with AET <4% off PPI have actionable GERD?
3. How should reflux-symptom association data on reflux monitoring tests be used for planning symptom management?
4. Is there a role for anti-reflux therapy in treating reflux hypersensitivity
5. The AET is 4-6% off PPI – now what?
6. Can total reflux episode count on impedance monitoring direct management?
7. What methods are available for clinical measurement of esophageal mucosal integrity?
8. What are the roles of mucosal impedance metrics in evaluating typical and atypical reflux symptoms?
9. Are there roles for barium esophagram and high-resolution manometry in GERD evaluation?
10. How can FLIP be utilized for GERD diagnosis and management?
11. What is the diagnostic approach to suspected reflux-related airway diseases?
12. How can reflux management protect the lungs in pre- and post-transplant patients?